JPS62503032A - 免疫応答の増加方法 - Google Patents

免疫応答の増加方法

Info

Publication number
JPS62503032A
JPS62503032A JP61502888A JP50288886A JPS62503032A JP S62503032 A JPS62503032 A JP S62503032A JP 61502888 A JP61502888 A JP 61502888A JP 50288886 A JP50288886 A JP 50288886A JP S62503032 A JPS62503032 A JP S62503032A
Authority
JP
Japan
Prior art keywords
igd
cells
lymphocytes
mammal
exposed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61502888A
Other languages
English (en)
Japanese (ja)
Inventor
コイコ，リチャード　エフ
ソーベック，ジャネット　ジー
Original Assignee
ニユ−ヨ−ク　ユニバ−シイテイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニユ−ヨ−ク　ユニバ−シイテイ filed Critical ニユ−ヨ−ク　ユニバ−シイテイ
Publication of JPS62503032A publication Critical patent/JPS62503032A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/13—B-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP61502888A 1985-04-23 1986-04-23 免疫応答の増加方法 Pending JPS62503032A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72608985A 1985-04-23 1985-04-23
US726089 1991-07-05

Publications (1)

Publication Number Publication Date
JPS62503032A true JPS62503032A (ja) 1987-12-03

Family

ID=24917187

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61502888A Pending JPS62503032A (ja) 1985-04-23 1986-04-23 免疫応答の増加方法

Country Status (3)

Country Link
EP (1) EP0220309A4 (de)
JP (1) JPS62503032A (de)
WO (1) WO1986006490A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919230D0 (en) * 1989-08-24 1989-10-04 Vaccine Research Foundation Li Method for in vivo testing of immunity in non-human subjects

Also Published As

Publication number Publication date
EP0220309A1 (de) 1987-05-06
EP0220309A4 (de) 1988-06-20
WO1986006490A1 (en) 1986-11-06

Similar Documents

Publication Publication Date Title
Lafleur et al. A quantitative assay for the progenitors of bone marrow-associated lymphocytes
Feldmann et al. The requirement of macrophages in the secondary immune response to antigens of small and large size in vitro
SHAW et al. Infection and immunity in chronic lymphocytic leukemia
Balkwill et al. Evidence for tumour necrosis factor/cachectin production in cancer
Johnson et al. Studies on the O antigen of Salmonella typhosa: V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide
Winkelstein et al. Heat labile opsonins to pneumococcus: III. The participation of immunoglobulin and of the alternate pathway of C3 activation
CA1206898A (en) Monoclonal antibodies specific to an antigen on the surface of mature human t cells
Alm et al. Antibody and immunoglobulin production at the cellular level in bursectomized-irradiated chickens
Laskov Rosette forming cells in non-immunized mice
Ceglowski et al. Immunosuppression by Leukemia Viruses: II. Cytokinetics of Appearance of Hemolysin-Forming Cells in Infected Mice During the Anamnestic Response to Sheep Erythrocytes
Sabin The Microscopic Agglutination Test in Pneumonia: Its Application to Rapid Typing and Control of Serum Therapy
Steinkuller et al. Studies on the mode of action of the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG)
Miller et al. Thymic dysplasia (“Swiss agammaglobulinemia”): II. Morphologic and functional observations
JPS62503032A (ja) 免疫応答の増加方法
US4937071A (en) Method for augmenting immune response
Moores et al. Severe hemolytic anemia in an adult associated with anti‐T
JPS61502680A (ja) 生化学的薬剤及びその製造方法
Barron et al. Reactions of Newcastle disease virus with infectious mononucleosis sera in agar gel
Hofmann et al. Protection of mice against tick-borne encephalitis by different classes of immunoglobulins
Levin et al. Production of 19S and 7S antibodies by cancer patients
Friedman et al. Comparison of Bacteriolysis, Passive Hemolysis, and Bacterial Adherence Colony Formation for Detecting Antibdy-Forming Cells
Baker et al. Suppression by progesterone of nonspecific in vitro lymphocyte stimulation in mice as a mechanism for the enhancement of herpes simplex virus type 2 vaginal infection
Boulanger et al. Hog Cholera: III. Investigation of the Complement-Fixation Test for the Detection of the Virus in Swine Tissue
Hosono et al. Studies on the resistance to tolerance induction against human IgG in DDD mice: I. Organ differences of tolerogen susceptibility and cellular sites responsible for the resistance
Davidsohn et al. Heterophilic antibodies following injection of blood group substances